Search results for " THROMBOSIS"

showing 10 items of 328 documents

Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolism

1999

AdultMaleCardiac Catheterizationmedicine.medical_specialtyPulmonary ArterymedicineHumansRadiology Nuclear Medicine and imagingIntensive care medicineAgedThrombectomybusiness.industryCoronary ThrombosisHemodynamicsGeneral MedicineMiddle Agedmedicine.diseasePulmonary embolismRadiographyCatheterEmbolismEvaluation Studies as TopicFemaleRadiologyPulmonary EmbolismRheologyCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Interventions
researchProduct

Occurrence of Cerebral Venous Sinus Thrombosis in Patients with Presumed Idiopathic Intracranial Hypertension

2005

Purpose To report the rate of occurrence of cerebral venous sinus thrombosis (CVST) in patients with presumed idiopathic intracranial hypertension (IIH). Design Retrospective chart review. Participants All patients diagnosed with papilledema from November 1, 2002, through October 31, 2003, at 3 tertiary care neuro-ophthalmology centers. Methods Consecutive patients with a diagnosis of papilledema from 3 tertiary care neuro-ophthalmology centers were identified. Patients with space-occupying lesions, hydrocephalus, or meningitis were excluded. The remaining patients were evaluated with lumbar puncture, magnetic resonance imaging (MRI), and magnetic resonance venography (MRV). Main Outcome Me…

AdultMaleCerebral veinsmedicine.medical_specialtyAdolescentMagnetic resonance angiographySinus Thrombosis IntracranialCerebrospinal Fluid PressureRisk FactorsmedicineHumansCerebral venous sinus thrombosisChildPapilledemaAgedRetrospective StudiesPseudotumor Cerebrimedicine.diagnostic_testLumbar puncturebusiness.industryPhlebographymedicine.diseaseCerebral VeinsHydrocephalusSurgeryOphthalmologyVenous thrombosisFemaleCerebrospinal fluid pressureIntracranial Thrombosismedicine.symptombusinessMagnetic Resonance AngiographyPapilledemaOphthalmology
researchProduct

Decision making in a presumptive case of STEMI-like myocarditis

2015

In youngmales, differential diagnosis during chest pain is not always easy. When ECG findings suggest a cardiac origin of such symptoms, myo-pericarditis is usually themost likely hypothesis, beingmore common than Acute Coronary Syndromes (ACS) in the first decades of life [1]. In the presence of ST segment elevation, Troponin release and ventricular wall motion abnormalities, the diagnosis can be challenging, though. In the young a lowcoronary risk profile and atypical symptoms seldom support a working diagnosis of Coronary Heart Disease (CHD), and, therefore, urgent coronary angiography is not recommended routinely, although cases of early ACS are not so rare. In October 2014 a 26-year-ol…

AdultMaleChest Painmedicine.medical_specialtyMyocarditisCath labClinical Decision-MakingMyocarditiPopulationMyocardial InfarctionCoronary AngiographyChest painElectrocardiographyCoronary thrombosisInternal medicinemedicineMyocardial infarctioneducationCreatine KinaseST depressioneducation.field_of_studybusiness.industrymedicine.diseaseTroponinCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessTIMIHumanInternational Journal of Cardiology
researchProduct

Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant

1998

A mutation in the prothrombin gene (G--A20210) has been associated with higher plasma prothrombin levels and an increased tendency for venous thrombosis.To determine whether the prothrombin A20210 allele is independently associated with the occurrence of venous thrombosis.Case-control study.Two thrombosis centers in southern Italy.281 consecutive patients with venous thrombosis confirmed by objective tests and 850 controls.Medical history was collected on standardized questionnaires. The presence of prothrombin G--A2020 and factor V Leiden mutations was determined by polymerase chain reaction. The presence of anticoagulant factors and prothrombin activity was determined by tests of function…

AdultMaleHeterozygotePathologymedicine.medical_specialtyAdolescentStatistics as TopicGastroenterologyRisk FactorsSurveys and Questionnaireshemic and lymphatic diseasesInternal medicineBlood plasmaInternal MedicinemedicineFactor V LeidenHumansPoint MutationRisk factorChildVeinAllelesAgedAged 80 and overbusiness.industryVascular diseaseFactor VGeneral MedicineMiddle AgedThrombophlebitismedicine.diseaseThrombosisPulmonary embolismVenous thrombosismedicine.anatomical_structureCase-Control StudiesChild PreschoolMutationFemaleProthrombinbusinesscirculatory and respiratory physiology
researchProduct

Thrombosis in inherited factor VII deficiency

2003

Thrombosis in congenital factor (F) VII deficiency was investigated through extensive phenotypic and molecular-genetic studies. Patients with a history of thrombosis among 514 entries in the FVII Deficiency Study Group database were evaluated. Thrombotic events were arterial in one case, disseminated intravascular coagulation in another and venous in seven. Gene mutations were characterized in eight patients: three were homozygous, three compound heterozygous and two heterozygous. FXa and IIa generation assays were consistent with the genetic lesions. One patient was heterozygous for the FV Leiden and one for the FIIG20210A mutation. In seven patients, surgical interventions and/or replacem…

AdultMaleHeterozygotemedicine.medical_specialtyPathologyTime FactorsAdolescentFactor VII DeficiencyGene mutationCompound heterozygosityThrombophiliaGastroenterologyInternal medicinemedicineHumansThrombophiliaAgedVenous ThrombosisDisseminated intravascular coagulationbiologybusiness.industryHomozygoteFactor VFactor VThrombosisHematologyCongenital FVII deficiency; Replacement therapy; Surgery; Thrombophilia; Thrombosis;Disseminated Intravascular CoagulationMiddle Agedmedicine.diseaseThrombosisZygosityVenous thrombosisPhenotypeDatabases as TopicFactor XaMutationbiology.proteinFemaleProthrombinbusinessJournal of Thrombosis and Haemostasis
researchProduct

Haemorheological profile in congenital afibrinogenemia and in congenital dysfibrinogenemia: A clinical case report

2019

Although the inherited quantitative and qualitative disorders of fibrinogen are rare, in the course of time patients may develop complications including episodes of arterial and venous thrombosis. It can be useful to complete the laboratory assessment of these clinical conditions with the evaluation of the haemorheological profile. The data obtained from this study showed that congenital afibrinogenemia was characterized by a primary plasma hypoviscosity, whereas congenital dysfibrinogenemia by a primary plasma hyperviscosity. Both these haemorheological alterations may concur, with different mechanisms, to the pathogenesis of thrombotic vascular complications.

AdultMaleHypoviscosityPediatricsmedicine.medical_specialtyPhysiologyHyperviscosity030204 cardiovascular system & hematologyFibrinogen030218 nuclear medicine & medical imagingYoung Adult03 medical and health sciences0302 clinical medicinePhysiology (medical)medicineHumansAfibrinogenemiabusiness.industryCongenital dysfibrinogenemiaFibrinogenHematologyMiddle AgedAfibrinogenemiamedicine.diseaseCongenital afibrinogenemiaVenous thrombosisFemaleClinical caseCardiology and Cardiovascular MedicinebusinessHumanmedicine.drugClinical Hemorheology and Microcirculation
researchProduct

Deep Venous Thrombosis: Leukocyte Rheology at Baseline and after in vitro Activation

2001

We evaluated leukocyte rheology, expressed as leukocyte filtration, polymorphonuclear (PMN) membrane fluidity and cytosolic Ca<sup>2+</sup> concentration in subjects with acute deep venous leg thrombosis (DVT). In 14 subjects with leg DVT we examined the leukocyte filtration [unfractionated, mononuclear cells (MN), PMNs], PMN membrane fluidity and PMN cytosolic Ca<sup>2+</sup> concentration. Subsequently, we evaluated the same PMN variables after in vitro chemotactic activation with 4-phorbol-12-myristate-13-acetate. At baseline, we observed a significant difference in the filtration of unfractionated and MNs and in PMN cytosolic Ca<sup>2+</sup> concentra…

AdultMalePathologymedicine.medical_specialtyMembrane FluidityNeutrophileDeep veinBiologyGranulocytePathogenesisPhysiology (medical)LeukocytesmedicineMembrane fluidityHumansCells CulturedAgedVascular diseaseHematologyMiddle AgedThrombophlebitismedicine.diseaseThrombosisChemotaxis LeukocyteVenous thrombosismedicine.anatomical_structureImmunologyCalciumFemaleRheologyPathophysiology of Haemostasis and Thrombosis
researchProduct

Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database

2020

Summary Background European estimates of the burden imposed by pulmonary embolism are not available to this date. We aimed to assess pulmonary embolism-related mortality and time trends in the WHO European Region. Methods We analysed vital registration data from the WHO Mortality Database (2000–15) covering subregions of the WHO European Region: Eastern Europe, Northern Europe, Southern Europe, Western Europe, and Central Asia. Deaths were considered pulmonary embolism-related if International Classification of Disease-10 code for acute pulmonary embolism (I26) or any code for deep or superficial vein thrombosis was listed as the primary cause of death. We used locally estimated scatterplot…

AdultMalePulmonary and Respiratory MedicineAdolescentDatabases FactualSuperficial vein thrombosisPopulation610 Medicine & healthWorld Health Organizationcomputer.software_genreYoung AdultCase fatality rateHumansMedicineeducationAgedCause of deathAged 80 and overeducation.field_of_studyDatabasebusiness.industryIncidenceIncidence (epidemiology)Mortality rate10031 Clinic for AngiologyMiddle Agedmedicine.diseasePulmonary embolismEurope2740 Pulmonary and Respiratory MedicineAsia CentralFemalePulmonary EmbolismbusinesscomputerCohort study
researchProduct

Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer

2008

Limited information exists on the incidence of symptomatic venous thromboembolism (vTE) in patients undergoing chest surgery for lung cancer. Several factors increase the thromboembolic risk in patients undergoing surgery for lung cancer: the intrinsic procoagulant effect of cancer,extensive surgical intervention, dependent limb position in the operating room, and vessel injury consequent to the operation. Furthermore,these patients might be especially vulnerable to pulmonary embolism (PE) because of the loss of lung tissue and the presence of chronic obstructive pulmonary disease and cardiovascular diseases caused by smoking.t Older studies found a very high incidence of thromboembolic eve…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentSeverity of Illness Indexvenous thromboembolism thoracotomySettore MED/15 - Malattie Del SangueCohort StudiesAge DistributionPostoperative ComplicationsRisk FactorsmedicineHumansMulticenter Studies as TopicThoracotomySex DistributionLung cancerPneumonectomyAgedNeoplasm StagingRetrospective StudiesAged 80 and overOntariobusiness.industryVascular diseaseIncidence (epidemiology)IncidenceRespiratory diseaseCancerAnticoagulantsRetrospective cohort studyVenous ThromboembolismMiddle Agedmedicine.diseasePrognosisSurvival AnalysisSurgeryVenous thrombosisItalyThoracotomyFemaleSurgerybusinessPulmonary EmbolismCardiology and Cardiovascular MedicineThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Incidence of liver retransplantation and its effect on patient survival.

2008

Purpose. The purpose of this study was to review our institutional experience with re-liver transplantation (OLT) after split and full-size OLT. Patients and methods. We evaluated data corresponding to retransplanted patients over an 8-year period who underwent deceased donor OLT at our institution. Variables analyzed included indications for primary OLT, and re-OLT, the type of graft used during the initial versus re-OLT, the time from initial to re-OLT, and patient survival after re-OLT. Results. Sixty-four of 697 first OLT (9.2%) required re-OLT. Forty-nine cases were among 637 (7.6%) full-size OLT, while 15 were among 60 (25%) split OLT (P <.001). Median time to re-OLT was 8 days (range…

AdultMaleReoperationmedicine.medical_specialtyAdolescentYoung AdultOverall survivalMedicineHumansSurvivorsAgedRetrospective StudiesTransplantationDeceased donorbusiness.industryIncidence (epidemiology)Patient SelectionPatient survivalHepatitis CMiddle Agedmedicine.diseaseSurgeryLiver TransplantationTransplantationSurvival RateHepatic artery thrombosissurgical procedures operativeMedian timeSurgeryFemalebusinessTransplantation proceedings
researchProduct